PCSK9 and cardiovascular disorder: Thus, it is evident that PCSK9 inhibitors not only effectively lower LDL-C but may also reduce the occurrence of cardiovascular events in high-risk patients, demonstrating their potential in the prevention of cardiovascular diseases.